Vitamin D supplementation does not improve DLBCL outcomes
A study found that low baseline vitamin D is associated with poor prognosis in patients with diffuse large B-cell lymphoma.
FDA grants accelerated approval to linvoseltamab in relapsed or refractory myeloma
The US Food and Drug Administration has granted accelerated approval to linvoseltamab (Lynozyfic) in adults patients with relapsed or refractory.
Low-intensity protocol targets MRD in ALL
In this video interview, Anastasia Vasileva, MD, a researcher at the National Research Center for Hematology in Moscow, discusses findings.
Dr. Kuykendall discusses VERIFY trial, rusfertide’s impact on PV treatment
Andrew Kuykendall, MD, assistant member in Malignant Hematology at Moffitt Cancer Center in Tampa, Florida, discusses the phase 3 VERIFY.
Top Categories
POPULAR NEWS
Abstract submissions now open for SOHO 2025
February 14, 2025
Asciminib benefit-risk profile bests other TKIs in CML
December 10, 2024
NCI’s myeloMATCH pushes the envelope in myeloid leukemia care
January 3, 2025
SOHO Insider Podcast
Meetings
Young Investigator Program
Ambassador Program
Editorial Board
Join Us Today and Become a Part of the SOHO Community
- Instant connections to our SOHO Communityof nearly 9,000 members
- Access to a comprehensive Resource Centerthat includes slides, publications, abstracts, videos & more
- Connection to our SOHO DocMatter Communityfor hematologic oncology discussions and education
- Free online access to our official journal, ‘Clinical Lymphoma Myeloma and Leukemia
- Free online and print subscription (US members) to our news publication,'SOHO Insider'
- Significant member-only discounts on meetings and events
- Early member-only registration and housing opportunities
- ... and much more!
SOHO Career Center
- Create a job seeker profile
- Perform intuitive searches for new jobs
- Auto-fill your resume through uploaded files
- Apply to new jobs through a streamlined workflow
- Receive email alerts when new relevant jobs are posted
To access the SOHO Career Center click the following link.
